Neurocrine Biosciences | NBIX - Capitalización De Mercado





Capitalización De Mercado Cambio Fecha
AbbVie USD 384.69B 19.14B 2026-03
Acadia Pharmaceuticals USD 3.8B 724M 2026-03
Agios Pharmaceuticals USD 2.01B 423M 2026-03
ALKERMES USD 5.88B 1.26B 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amgen USD 189.89B 13.64B 2026-03
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.86B 553M 2026-03
Cytokinetics USD 8.19B 420M 2026-03
Enanta Pharmaceuticals USD 122M 98M 2024-12
Exelixis USD 10.89B 857M 2026-03
Gilead Sciences USD 172.99B 20.71B 2026-03
Halozyme Therapeutics USD 7.66B 257M 2026-03
Incyte USD 18.73B 660M 2026-03
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Nektar Therapeutics USD 12.82B 11.96B 2026-07
Neurocrine Biosciences USD 13.25B 890M 2026-03
Pfizer USD 153.81B 12.24B 2026-03
Prothena USD 526M 10M 2026-07
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Repligen USD 6.64B 2.58B 2026-03
Sarepta Therapeutics USD 2.28B 30M 2026-03
Teva Pharmaceutical Industries USD 34.27B 2.14B 2026-03
Ultragenyx Pharmaceutical USD 2.06B 159M 2026-03
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03